Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 73124 CHICAGO, IL
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$165,214
-$1,844 QoQ
Shares Held
26,996
-14.5% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 43 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. VRCA ranks #331 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in VRCA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $165,214 26,996
2026-03-31 $167,058 31,580
2025-12-31 $166,398 20,024
2025-09-30 $86,332 20,031
2025-06-30 $109,922 207,402
2025-03-31 $192,157 434,748
2024-12-31 $151,921 217,032
2024-09-30 $317,699 219,104
2024-06-30 $1,390,020 190,675
2024-03-31 $1,176,433 198,722
2023-12-31 $1,455,808 198,881
2023-09-30 $728,352 187,478
2023-06-30 $1,091,424 189,155
2023-03-31 $334,203 51,416
2022-12-31 $131,485 47,813
2022-09-30 $140,586 48,146
2022-06-30 $79,581 41,449
2022-03-31 $1,102,602 135,956
2021-12-31 $1,280,906 139,837
2021-09-30 $1,755,662 140,453
2021-06-30 $1,660,172 146,918
2021-03-31 $2,301,511 151,915
2020-12-31 $2,047,259 177,868
2020-09-30 $1,452,108 187,611
2020-06-30 $1,304,189 118,455
2020-03-31 $1,657,620 151,658